Medical technology company discloses SEC investigation

Pulse Biosciences, Inc., a clinical-stage medical technology company headquartered in Hayward, California, disclosed in a US Securities and Exchange Commission filing that the company and several of its directors have received subpoenas from the SEC.  According to Pulse, the SEC is seeking information about trading of the company's stock in advance of the financing announcement made by the company in September 2017.  Pulse says that it is cooperating with the investigation.

Form 10-K

You are currently offline.